ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751623 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751623; 2) Community: the network communities that were significantly associated with the response to NSC 751623; 3) Molecule: the relationships between components within communities and NSC 751623; 4) MDR: the compounds that were significantly associated with the NSC 751623.

NSC Compound Enrichment Correlation
NSC 645253 Null 0.0179905510964914 0.37107734
NSC 648365 Insulin-Methotrexate conjugate 0.0179905510964914 0.49547355
NSC 668833 Null 0.0179905510964914 -0.18243248
NSC 670337 Null 0.0179905510964914 0.57574354
NSC 671165 Null 0.0179905510964914 0.48558198
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.0179905510964914 0.48963017
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0179905510964914 0.32591307
NSC 682841 Null 0.0179905510964914 0.38874097
NSC 683692 .alpha.-D-Glucopyranoside, phenylmethyl 2-acetylamino-2-deoxy- 3-O-[[2-[[2-[1-(aminocarbonyl)-4-[[5-[(1-nitro- 9-acridinyl)amino]pentyl]amino]-4-oxobutyl]amino]- 1-methyl-2-oxoethyl]amino]-1-methyl-2 0.0179905510964914 0.20873379
NSC 692581 Null 0.0179905510964914 0.49628896
Total:127  Current:58    [First] [Prev] [Next] [Last]